Journal of Cardiovascular Computed Tomography
Volume 2, Issue 5 , Pages 344-348 , September 2008

From the Desk of the President: The Way Ahead

References 

  1. Reddy KS. Cardiovascular disease in non-Western countries. N Engl J Med. 2004;350:2438–2440
  2. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med. 2007;356:2388–2398
  3. Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991;11:88–94
  4. Meijboom WB, van Mieghem CA, Mollet NR, Pugliese F, Weustink AC, van Pelt N, et al. 64-slice computed tomography coronary angiography in patients with high, intermediate, or low pretest probability of significant coronary artery disease. J Am Coll Cardiol. 2007;50:1469–1475
  5. Budoff MJ, Dowe D, Jollis JG, Gitter M, Sutherland J, Halamert E, et al. Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the Prospective Multicenter ACCURACY (assessment by coronary computed tomographic angiography of individuals undergoing invasive coronary angiography) Trial. J Am Coll Cardiol. 2008;first published on Aug 22 as doi:10.1016/j.jacc.2008.07.031
  6. Fleischmann KE, Hunink MG, Kuntz KM, Douglas PS. Exercise echocardiography or exercise SPECT imaging? (A meta-analysis of diagnostic test performance). Jama. 1998;280:913–920
  7. Imran MB, Khan MA, Aslam MN, Irfanullah J. Diagnosis of coronary artery disease by stress echocardiography and perfusion scintigraphy. J Coll Physicians Surg Pak. 2003;13:465–470
  8. Kim C, Kwok YS, Heagerty P, Redberg R. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis. Am Heart J. 2001;142:934–944
  9. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–1345
  10. See R, Lindsey JB, Patel MJ, Ayers CR, Khera A, McGuire DK, et al. Application of the screening for Heart Attack Prevention and Education Task Force recommendations to an urban population: observations from the Dallas Heart Study. Arch Intern Med. 2008;168:1055–1062
  11. Nasir K, Michos ED, Blumenthal RS, Raggi P. Detection of high-risk young adults and women by coronary calcium and National Cholesterol Education Program Panel III guidelines. J Am Coll Cardiol. 2005;46:1931–1936
  12. Min J, Shaw L, Berman D, Gilmore A, Kang N. Costs and clinical outcomes in individuals without known coronary artery disease undergoing coronary computed tomographic angiography from an analysis of Medicare category III transaction codes. Am J Cardiol. 2008;102:672–678
  13. Dhruva SS, Redberg RF. Variations between clinical trial participants and Medicare beneficiaries in evidence used for Medicare national coverage decisions. Arch Intern Med. 2008;168:136–140
  14. Naghavi M, Falk E, Hecht HS, Jamieson MJ, Kaul S, Berman D, et al. From vulnerable plaque to vulnerable patient-part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) task rorce report. Am J Cardiol. 2006;98:2–15

PII: S1934-5925(08)00561-3

doi: 10.1016/j.jcct.2008.08.010

Journal of Cardiovascular Computed Tomography
Volume 2, Issue 5 , Pages 344-348 , September 2008

Article Tools